Scavenger receptor A: a new route for adenovirus 5

Hidde J Haisma1, Marije Boesjes, Antoine M Beerens

  • 1Department of Therapeutic Gene Modulation, Groningen University Institute for Drug Exploration, University of Groningen, The Netherlands.

Molecular Pharmaceutics
|February 21, 2009
PubMed

Insights

Researchers discovered that scavenger receptor A (SR-A) mediates adenovirus uptake by liver macrophages. Blocking this receptor in vivo enhances adenovirus gene therapy efficacy by reducing viral clearance.

Area of Science:

  • Virology
  • Immunology
  • Gene Therapy

Background:

  • Adenoviruses are common pathogens and utilized as vectors in gene therapy.
  • Systemic administration of adenoviruses leads to rapid clearance by liver macrophages, limiting gene therapy efficacy.
  • The mechanisms of adenoviral tropism and degradation in macrophages are not well understood.

Purpose of the Study:

  • To elucidate the mechanism of adenoviral uptake and degradation by macrophages.
  • To identify the specific receptor responsible for adenoviral tropism in macrophages.
  • To explore strategies for improving adenovirus-mediated gene therapy.

Main Methods:

  • Utilized Chinese hamster ovary (CHO) cells and J774 macrophage cell lines.
  • Investigated adenoviral transgene expression in SR-A expressing cells.
  • Assessed the effect of SR-A ligands on adenoviral uptake.
  • Performed electron microscopy on infected macrophages.
  • Conducted in vivo experiments in mice with blocked SR-A.

Main Results:

  • Identified scavenger receptor A (SR-A) as a novel adenoviral receptor on macrophages.
  • SR-A expression enhanced adenoviral transgene expression in CHO cells.
  • SR-A ligands significantly reduced adenoviral uptake in J774 cells.
  • Electron microscopy revealed adenoviral degradation pathways in macrophages.
  • Blocking SR-A in vivo decreased adenoviral clearance in liver macrophages.

Conclusions:

  • Scavenger receptor A (SR-A) mediates adenoviral uptake and subsequent degradation in macrophages.
  • Understanding and inhibiting adenoviral SR-A interaction can enhance gene therapy efficiency.
  • This discovery provides a basis for improving adenoviral vector delivery and efficacy.

Related Concept Videos

Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Receptor-Mediated Endocytosis01:20

Receptor-Mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...